Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00297453 · ClinicalTrials.gov registry record · Phase 3
Smoking Treatment in HIV Clinical Care Settings
A Phase 3 study of Nicotine Dependence, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 3
- Development phase
- 207
- Enrollment target
- 1
- Study location
NCT00297453 is a Phase 3 study of Nicotine Dependence that has completed, run by University of California, San Francisco. The registered enrollment target is 207 participants, above the 184-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (13% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00297453, a Phase 3 study of Nicotine Dependence, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 207 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is designed to evaluate and compare the efficacy and cost effectiveness of 3 smoking cessation treatments with HIV-positive cigarette smokers. The treatments include face-to-face individual counseling, a computer-Internet-based self-help treatment and a self-help manual treatment.
Conditions Studied
Interventions
- BEHAVIORAL Individual Counseling
- BEHAVIORAL Internet-based smoking treatment
- BEHAVIORAL self-help
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2006-01 |
| Est. Completion | 2011-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00297453
The ClinicalTrials.gov registry entry for NCT00297453 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 207 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 184-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (13% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Nicotine Dependence appearing as the primary indexed condition, and to 3 interventions - of which Individual Counseling is the first listed.
NCT00297453 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00297453 about?
NCT00297453 is a clinical study titled "Smoking Treatment in HIV Clinical Care Settings". The study is designed to evaluate and compare the efficacy and cost effectiveness of 3 smoking cessation treatments with HIV-positive cigarette smokers. The treatments include face-to-face individual counseling, a computer-Internet-based self-help treatment and a self-help manual treatment.
What is the current status of trial NCT00297453?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 207 participants. The study started on 2006-01. Estimated completion is 2011-01.
What conditions does trial NCT00297453 study?
This clinical trial studies the following conditions: Nicotine Dependence.
What interventions are being tested in trial NCT00297453?
The interventions under investigation include: Individual Counseling (BEHAVIORAL), Internet-based smoking treatment (BEHAVIORAL), self-help (BEHAVIORAL).
Who is sponsoring clinical trial NCT00297453?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00297453 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nicotine Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Optimizing Tobacco Use Treatment for PLWHA
RECRUITING · Phase 3
-
Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.
RECRUITING · Phase 3
-
Bupropion Treatment for Youth Smoking Cessation
COMPLETED · Phase 3
-
Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC)
RECRUITING · NA
-
Effects of Cannabidiol on Stress and Nicotine Withdrawal
RECRUITING · Phase 1
-
Overcoming Nicotine Dependence to Enable Quitting
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.